Repligen (RGEN) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $0.26.
- Repligen's EPS (Weighted Average and Diluted) rose 270000.0% to $0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year increase of 10769.23%. This contributed to the annual value of -$0.46 for FY2024, which is 17301.59% down from last year.
- Repligen's EPS (Weighted Average and Diluted) amounted to $0.26 in Q3 2025, which was up 270000.0% from $0.26 recorded in Q2 2025.
- In the past 5 years, Repligen's EPS (Weighted Average and Diluted) ranged from a high of $0.88 in Q2 2022 and a low of -$0.61 during Q4 2024
- In the last 5 years, Repligen's EPS (Weighted Average and Diluted) had a median value of $0.3 in 2023 and averaged $0.33.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 13294.12% in 2023, then soared by 270000.0% in 2025.
- Repligen's EPS (Weighted Average and Diluted) (Quarter) stood at $0.5 in 2021, then soared by 70.0% to $0.85 in 2022, then tumbled by 132.94% to -$0.28 in 2023, then crashed by 117.86% to -$0.61 in 2024, then surged by 142.62% to $0.26 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.26 for Q3 2025, versus $0.26 for Q2 2025 and $0.1 for Q1 2025.